In addition, it could be seen that non-conjugated APPZ decreased tumor cells’ proliferation rate, possible due to piperazine antioxidant effect [45], but that such treatment did not affect non-HER2-overexpressing cells’ survival rate. Here, ERBB2 is linked to neoplasm.